Citations for
1AHDS, SPART, SPG1, SPG10, SPG11, SPG12, SPG13, SPG14, SPG15, SPG16, SPG17, SPG19, SPG2, SPG21, SPG23, SPG24, SPG25, SPG26, SPG27, SPG28, SPG29, SPG30, SPG31, SPG32, SPG33, SPG35, SPG36, SPG37, SPG38, SPG39, SPG41, SPG41, SPG42, SPG43, SPG44, SPG45, SPG46, SPG47, SPG48, SPG49, SPG50, SPG51, SPG52, SPG53, SPG54, SPG55, SPG56
Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.
Fink JK.
Acta Neuropathol 126(3):307-28. doi: 10.1007/s00401-013-1115-8. Epub 2013 Jul 30. 2013
2SPG21
Targeted disruption of the Mast syndrome gene SPG21 in mice impairs hind limb function and alters axon branching in cultured cortical neurons.
Soderblom C, Stadler J, Jupille H, Blackstone C, Shupliakov O, Hanna MC.
Neurogenetics 2010
3ALDH16A1, SPG21
Interaction of the SPG21 protein ACP33/maspardin with the aldehyde dehydrogenase ALDH16A1.
Hanna MC, Blackstone C.
Neurogenetics 10(3):217-28. Epub 2009 Jan 31. 2009
4NIPA1, SPART, SPAST, SPG21, ZFYVE26
The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling.
Tsang HT, Edwards TL, Wang X, Connell JW, Davies RJ, Durrington HJ, O'Kane CJ, Luzio JP, Reid E.
Hum Mol Genet 18(20):3805-21. Epub 2009 Jul 20.PMID: 19620182 2009
5ATG101, C1orf59, CCDC51, CD37, CTF8, GLYAT, GSDMB, NDUFAF6, SPG21, TIAM2, ZNF35
Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.
Suzuki Y, Yamashita R, Shirota M, Sakakibara Y, Chiba J, Mizushima-Sugano J, Nakai K, Sugano S.
Genome Res 14(9):1711-8. 2004
6SPG21
Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia.
Simpson MA, Cross H, Proukakis C, Pryde A, Hershberger R, Chatonnet A, Patton MA, Crosby AH.
Am J Hum Genet 73(6):1147-56. Epub 2003 Oct 16. 2003
7SPG21
Cloning of ACP33 as a novel intracellular ligand of CD4.
Zeitlmann L, Sirim P, Kremmer E, Kolanus W.
J Biol Chem 276(12):9123-32. 2001